UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

British journal of cancer, 2007-12, Vol.97 (11), p.1480-1485

2007

Volltextzugriff (PDF)

Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib

European journal of cancer (1990), 2007-01, Vol.43 (1), p.55-63

2007

Volltextzugriff (PDF)

Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours

Current oncology (Toronto), 2012-02, Vol.19 (1), p.e28-35

2012

Volltextzugriff (PDF)

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

British journal of cancer, 2008-11, Vol.99 (10), p.1579-1585

2008

Volltextzugriff (PDF)

Metronomic anti-cancer therapy – an ongoing treatment option for advanced cancer patients

Journal of cancer therapeutics & research, 2012, Vol.1 (1), p.32

2012

Volltextzugriff (PDF)

Drug-drug interaction pharmacokinetic study with the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with irinotecan (CPT-11) in patients with solid tumors

International journal of clinical pharmacology and therapeutics, 2003-12, Vol.41 (12), p.618-619

2003

Volltextzugriff (PDF)

Phase I study of BAY 73–4506, a multikinase inhibitor, administered for 21 days on/7 days off in patients with advanced solid tumors

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3593-3593

2007

Volltextzugriff (PDF)

A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3069-3069

2006

Volltextzugriff (PDF)

Phase I study of BAY 43–9006 (sorafenib), a Raf kinase and VEGFR inhibitor, combined with irinotecan (CPT-11) in advanced solid tumors

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3115-3115

2005

Volltextzugriff (PDF)

Phase II study of Sorafenib (BAY 43–9006) in hormone-refractory patients with prostate cancer: A study of the Central European Society for Anticancer Drug Research—EWIV (CESAR)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3094-3094

2006

Volltextzugriff (PDF)

Phase I dose escalating study of PEG-PGA and DON (GlutaDON): A new amino acid depleting anti cancer drug approach

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3175-3175

2004

Volltextzugriff (PDF)

Phase I dose escalating study of PEG-PGA and DON (GlutaDON): A new amino acid depleting anti cancer drug approach

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3175-3175

2004

Volltextzugriff (PDF)

Adjuvant and palliative anticancer treatment of colon carcinoma in 2004

Praxis (Bern. 1994), 2004-09, Vol.93 (40), p.1633

2004

Volltextzugriff (PDF)

401 POSTER Pharmacokinetic characterization of BI 2536 - a novel Plk1 inhibitor - in advanced cancer patients

European journal of cancer supplements, 2006-11, Vol.4 (12), p.123-123

2006

Volltextzugriff (PDF)

Die systemische Therapie des Kolonkarzinoms 2004

Praxis (Bern. 1994), 2004-09, Vol.93 (40), p.1633-1644

2004

Volltextzugriff (PDF)

A Phase I Dose―Escalation Study of Regorafenib (BAY 73―4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

Clinical cancer research, 2012-05, Vol.18 (9), p.2658-2667

2012

Volltextzugriff (PDF)

Integration of sensors in sandwich composites for the detection of structural damage

Journal of physics. Conference series, 2023-06, Vol.2526 (1), p.12069

2023

Volltextzugriff (PDF)

Changes in electric resistance of cracked copper-coated, pitch-based carbon fibres for structural health monitoring in a glider wing

Journal of physics. Conference series, 2023-06, Vol.2526 (1), p.12066

2023

Volltextzugriff (PDF)

Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5511-5517

2008

Volltextzugriff (PDF)

A sensor detecting kissing bonds in adhesively bonded joints using electric time domain reflectometry

NDT & E international : independent nondestructive testing and evaluation, 2019-03, Vol.102, p.114-119

2019

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin

Clinical cancer research, 2007-08, Vol.13 (16), p.4858-4866

2007

Volltextzugriff (PDF)

Development of a smart implant for monitoring spinal stabilization using a rod-integrated measurement system

Brain & spine, 2024, Vol.4, p.103137, Article 103137

2024

Volltextzugriff (PDF)

Functional Design Employing Miniaturized Electronics with Wireless Signal Provision to a Smartphone for a Strain-Based Measuring System for Ski Poles

Computers (Basel), 2021-06, Vol.10 (6), p.77

2021

Volltextzugriff (PDF)

Strain-based monitoring system for ski poles with low impact on their total mass and inertia

Procedia manufacturing, 2020, Vol.52, p.187-192

2020

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(27)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Humans
(11)
Life Sciences & Biomedicine
(10)
Oncology
(10)
Middle Aged
(9)
Aged
(8)
Female
(8)
Male
(8)
Adult
(7)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Neoplasms - Drug Therapy
(7)
Technology
(5)
Tumors
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Dose-Response Relationship, Drug
(4)
Pharmacology. Drug Treatments
(4)
Treatment Outcome
(4)
Aged, 80 And Over
(3)
Antineoplastic Agents
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib

Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours

Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours

Metronomic anti-cancer therapy – an ongoing treatment option for advanced cancer patients

Drug-drug interaction pharmacokinetic study with the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with irinotecan (CPT-11) in patients with solid tumors

Phase I study of BAY 73–4506, a multikinase inhibitor, administered for 21 days on/7 days off in patients with advanced solid tumors

A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors

Phase I study of BAY 43–9006 (sorafenib), a Raf kinase and VEGFR inhibitor, combined with irinotecan (CPT-11) in advanced solid tumors

Phase II study of Sorafenib (BAY 43–9006) in hormone-refractory patients with prostate cancer: A study of the Central European Society for Anticancer Drug Research—EWIV (CESAR)

Phase I dose escalating study of PEG-PGA and DON (GlutaDON): A new amino acid depleting anti cancer drug approach

Phase I dose escalating study of PEG-PGA and DON (GlutaDON): A new amino acid depleting anti cancer drug approach

Adjuvant and palliative anticancer treatment of colon carcinoma in 2004

401 POSTER Pharmacokinetic characterization of BI 2536 - a novel Plk1 inhibitor - in advanced cancer patients

Die systemische Therapie des Kolonkarzinoms 2004

A Phase I Dose―Escalation Study of Regorafenib (BAY 73―4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

Integration of sensors in sandwich composites for the detection of structural damage

Changes in electric resistance of cracked copper-coated, pitch-based carbon fibres for structural health monitoring in a glider wing

Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors

A sensor detecting kissing bonds in adhesively bonded joints using electric time domain reflectometry

Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin

Development of a smart implant for monitoring spinal stabilization using a rod-integrated measurement system

Functional Design Employing Miniaturized Electronics with Wireless Signal Provision to a Smartphone for a Strain-Based Measuring System for Ski Poles

Strain-based monitoring system for ski poles with low impact on their total mass and inertia

Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project

Suchergebnisse filtern